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LETTER
Homologous recombination in human
embryonic stem cells using CRISPR/Cas9
nickase and a long DNA donor template
Dear Editor,
Genome editing of human embryonic stem cells (hESCs) is
critical for basic biological research and regenerative medi-
cine. However, until a few years ago, gene targeting tech-
nologies to disrupt, repair or overexpress genes in hESCs
had been very inefﬁcient and thus could not be routinely
used. Recent technical breakthrough includes bacterial arti-
ﬁcial chromosome based high efﬁciency gene targeting
(Song et al., 2010), as well as the successful engineering of
two systems of site-speciﬁc nucleases, zinc-ﬁnger nucleases
(ZFNs) and transcription activator-like effector nucleases
(TALENs) (Hockemeyer et al., 2009; Hockemeyer et al.,
2011). The two engineered nucleases are composed of
programmable and sequence-speciﬁc DNA-binding mod-
ules, which bring the nucleases to speciﬁc genomic site to
introduce a DNA double-strand break. However, these two
technologies have several limitations, including the time-
consuming and labor-intensive experimental design, and the
risk of off-targeting mutations (Gaj et al., 2013). More
recently, a new genome-editing technology, denoted the
clustered regularly interspaced short palindromic repeats
(CRISPR)/CRISPR-associated (Cas) system, has been
developed for efﬁcient gene targeting in cells of various
species, including zebraﬁsh (Hwang et al., 2013), mouse
(Wang et al., 2013), monkey (Niu et al., 2014), and human
(Cong et al., 2013; Mali et al., 2013b). In this system, Cas9
nuclease is targeted to a speciﬁc genomic site by complex-
ing with a guide RNA, which hybridizes a 20-nucleotide DNA
sequence immediately preceding an NGG motif, introducing
a double-strand break three nucleotides upstream of the
NGG motif (Jinek et al., 2012). Compared to ZFNs and TA-
LENs, CRISPR/Cas9 system offers simple experimental
design and very high targeting efﬁciency (Ding et al., 2013).
However, some studies have also raised the concern about
the off-target mutation effect of this system (Hsu et al., 2013;
Mali et al., 2013a). To reduce the off-target mutations, a
D10A mutant nickase version of Cas9 (Cas9n) has been
developed to replace wild type Cas9 and shown to increase
the ratio of homology-directed repair (HDR) to nonhomolo-
gous end joining (NHEJ) (Cong et al., 2013; Mali et al.,
2013b). However, the targeting efﬁciency of Cas9n is much
lower than wild type Cas9, raising the concern that it cannot
be applied in homologous recombination (HR) in hESCs.
To test whether Cas9n can induce precise gene targeting
via homologous recombination at a gene locus not expressed
in hESCs, we designed the experiment to employ Cas9n and
a long DNA donor template to introduce a drug resistance
gene into a lineage-speciﬁc locus. We picked the gene locus
of pulmonary surfactant protein C (SFTPC), which is specif-
ically expressed in pulmonary alveolar type II cells (Degryse
et al., 1996). In the long DNA donor template, an IRES-Puro-
pA expression cassette was inserted between the stop codon
and the polyA signal sequence of SFTPC gene with two
homologous arms around 1 kb. sgRNA-1 (#1 in Fig. 1A),
which targeted the site about 170 bps upstream of the junc-
tion site of the two homologous arms, was designed
according to the UCSC genome browser tracks developed by
Zhang lab at MIT. While, sgRNA-2 (#2 in Fig. 1A), which
targeted the junction site, was designed according to
(N)20NGG rule. The Cas9n expression cassette, sgRNAs
and donor DNA were electroporated into HUES3 hESCs.
After puromycin selection, 37 and 36 clones survived with the
transfection of sgRNA-1 and sgRNA-2, respectively. Five
clones derived from sgRNA-1 transfection were found to be
homologous recombinants at the upstream arm by PCR
screening, while no clone derived from sgRNA-2 transfection
was homologous recombinant (Fig. 1F). To conﬁrm that the
clones with homologous recombination at 5′ homologous arm
do not harbor random integration, the genomic DNA was
examined by Southern blotting with the upstream, down-
stream and internal probes, and with two restriction enzymes.
As shown in Fig. 1D, two clones were identiﬁed to have
precise HR at both arms and no random integration. The
other three clones were identiﬁed to have single-crossover at
the upstream homologous arm (data not shown). By tran-
siently expressing Flp, the F5 ﬂanked selection cassette was
removed, leading to the knock-in allele (Fig. 1E).
In this study, we demonstrate that Cas9n can induce
precise gene targeting via HR in hESCs with a long DNA
donor template. The targeting efﬁciency is around 5% (2/37)
in HUES3 cells (Fig.1F). In contrast to the oligonucleotide-
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mediated gene targeting with wild type Cas9 that enables
homozygous targeting of both alleles, no homozygous
knock-in clones were identiﬁed in this study. To achieve
homozygous knock-in clones with long DNA templates, a
“double nicking” strategy might be employed with paired
offset guide RNAs to signiﬁcantly increase the homozygous
targeting efﬁciency (Ran et al., 2013). We found three single-
crossover clones with homologous recombination occurred
only at the 5′ homologous arm. Therefore, our ﬁndings
highlight the importance to conﬁrm the homologous recom-
bination events at both arms of the introduced donor DNA. In
this context, in order to identify correctly targeted clones,
both the upstream and downstream HR events as well as






Figure 1. CRISPR/Cas9 nickase induces precise gene targeting through homologous recombination in hESCs using a long
DNA donor template. (A) The endogenous human SFTPC locus. The arrow indicates SFTPC gene. The stop codon (TAG) and the
two targeting sites (#1 and #2) of guide RNA are indicated. The locations of upstream and downstream probes for Southern blotting
and the sizes of WT NdeI (N) and SpeI (S) restriction fragments are shown. (B) The long DNA donor template. The sizes and
locations of homologous arms are indicated. The IRES-Puro-pA fragment and the F5 ﬂanked selection cassette were inserted
between the stop codon and the polyA signal sequence of SFTPC gene. Primers (a and b) used to screen homologous recombination
at upstream arm are indicated. (C) The conﬁguration of the knock-in allele. The location of internal probe for Southern blotting and the
sizes of mutant NdeI and SpeI restriction fragments are indicated. Primers (c, d and e) used to screen clones after Flp transient
expression are shown. (D) Southern blotting analysis of the clones with HR at upstream arm identiﬁed by PCR screening. Genomic
DNA was digested with NdeI or SpeI and hybridized to the upstream, internal and downstream probes sequentially with stripping
between probes. The WT and KI bands are indicated. Bands generated by single-crossover at the upstream homologous arm are
indicated by asterisks. (E) Excision of selection cassette was conﬁrmed by PCR analysis. Flp expression plasmid was introduced into
the HUES3 KI cells by electroporation. Genomic DNA isolated from individual clones was examined by PCR. Primers c and d amplify
a 264-bp fragment in KI cells with the selection cassette, while primers c and e amplify a 329-bp fragment in KI cells after the selection
cassette is excised. BAC plasmid without selection cassette was used as a positive control. (F) Summary of the frequency of
homologous recombination in hESCs.
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In summary, our studies indicate that Cas9n can achieve
precise gene targeting via HR in hESCs with a long DNA tem-
plate, allowinghighﬁdelityandcomplexgeneticmanipulationof
hESCs. One such application is to develop lineage-speciﬁc
reporter lines to trace the lineage differentiation of hESCs.
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